Pharmacolog announces Investment Memorandum and date for investor meetings before a rights issue
THE INFORMATION IN THIS PRESS RELEASE MAY NOT BE PUBLISHED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, TO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, USA OR ANY OTHER JURISDICTION WHERE PUBLICATION OR DISTRIBUTION OF THE INFORMATION IS AGAINST, OR REQUIRES REGISTRATION, ACCORDING TO APPLICBLE RULES. Pharmacolog in Uppsala AB (publ) ("Pharmacolog" or "The Company") has prepared an Investment Memorandum regarding the forthcoming new issue of shares with preferential rights for the Company's existing shareholders, which was published on 10